TrialJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2013

A randomized phase II study of gemcitabine and carboplatin with or without cediranib as first-line therapy in advanced non-small-cell lung cancer: North Central Cancer Treatment Group Study N0528.

Grace K Dy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.